Cannabis Use: Clinical Trials

6 trials for Cannabis Use, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 not yet recruiting, 1 active not recruiting, 1 completed, 1 unknown. 6 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 16Not yet recruiting 3, Active not recruiting 1, Completed 1, Unknown 1

Follow Cannabis Use: new trials by email Literature Review of Cannabis Use trials Research Report on Cannabis Use

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Research Investigating Drug Effects-2 (RiDE-2)
Placebo Oral Capsule, THC - Cannabis Use, Substance Use Disorder (SUD)
Early Phase 1Not yet recruitingUniversity of Illinois at Chicago1442027-01-042026-10-22
Lung Health and Breath Biomarkers: Acute Effects of Inhaled Cannabis
Cannabis (THC), Tobacco Cigarette - Cannabis Use, Tobacco
Early Phase 1Not yet recruitingHannah Harris122026-11-012026-10-06
THC + CBD and Memory Study
High THC/No CBD Marihuana, High THC/High CBD Marihuana, No THC/No CBD Marihuana - Marijuana Use, Cannabis Use
Early Phase 1Not yet recruitingHartford Hospital92025-12-012025-03-17
Effect of Cannabidiol (CBD) on Vision and Driving
Placebo (CBD 0%), CBD 15%, CBD 30% - Cannabis Use
Early Phase 1UnknownUniversidad de Granada602023-02-012024-03-22
Reward and Drug Effects on Mood and Brain Response
Placebo oral capsule, THC - Cannabis Use, Healthy
Early Phase 1CompletedUniversity of Illinois at Chicago1412021-03-162025-05-21
Probing the Cannabinoid System in Individuals With a Family History of Psychosis
Placebo, Very Low Dose THC, Low Dose THC - Psychosis, Cannabis Use
Early Phase 1Active not recruitingYale University212014-01-012025-06-10

Narrower conditions

Marijuana Abuse (4)  ·  Marijuana Use (1)  ·  Psychotic Disorders (1)  ·  Schizophrenia (1)  ·  Substance-Related Disorders (1)  ·  Vaping (1)

Broader conditions

Chemically-Induced Disorders (5)  ·  Mental Disorders (5)  ·  Substance-Related Disorders (4)  ·  Behavior (2)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (1)  ·  Smoking (1)

Interventions

Dronabinol (4)  ·  Glucose (1)  ·  nabiximols (1)

Sponsors

University of Illinois at Chicago (2)  ·  Hannah Harris (1)  ·  Hartford Hospital (1)  ·  Universidad de Granada (1)  ·  Yale University (1)

Countries

United States (4)  ·  Spain (1)

Top investigators

Alecia Dager, PhD (1)  ·  Godfrey Pearlson, MD (1)  ·  Hannah M Harris, Ph.D. (1)  ·  Michael Stevens, PhD (1)  ·  Mohini Ranganathan, MD (1)  ·  Natania A Crane, PhD (1)

NIH funding

K23DA048132 (1)